Position Responsibilities:
- Build a comprehensive Global and US training strategy aligned with business objectives to enhance knowledge and skills on SMA and apitegromab across U.S. and global markets.’.
- Lead and oversee commercial training initiatives.
- Experience leading "development" initiatives, i.e., training, coaching, learning initiatives
- Define and implement optimal learning strategies—including live/virtual instructor-led sessions, e-learning, blended, and social learning—leveraging best practices in instructional design.
- Own all curriculum components requiring promotional review and legal/regulatory/compliance approval, ensuring accuracy and adherence to standards.
- Lead creation and standardization of Launch Excellence frameworks from early planning through post-launch sustainment.
- Design and train on learning solutions grounded in adult learning theory to maximize knowledge of retention and application.
- Oversee development and facilitation of dynamic workshops on disease states, products, market landscapes, and contextual selling skills for diverse audiences.Train and coach leaders for key conversations that drive team performance, enabling high confidence in the performance of team members
- Coach leaders to ensure that employees receive balanced and actionable feedback
- Partner with executive leaders to provide the strategic guidance aligning people programs to business outcomes and ensuring high employee engagement
- Lead, evaluation and monitor training programs to ensure success and follow up to ensure training objectives are met
- Ensure the appropriate utilization of resources by overseeing the identification and selection of vendors as well as existing relationships and projects relating to training
- Lead end-to-end training efforts that deliver the measurable results aligned with project goals
- Design and implement practices that enable continuous improvement of a high-performance culture
- Other duties as assigned
Candidate Requirements:
- Bachelor’s degree in business, science or related field. A master’s degree (MBA) is strongly preferred.
- 10+ years of experience working in the pharmaceutical or biotech industry with 8+ years of experience in sales/commercial training.
- Ability to lead all commercial trainings
- Experience leading "development" initiatives, i.e., training, coaching, learning initiatives
- Firm understanding and applicability of adult learning theory framework
- Strong interpersonal skills with demonstrated ability to drive toward consensus
- Exceptional, persuasive, written, and verbal communication skills. Willingness to present the facts and put forth hypothesis in the face of differing opinions
- Excellent presentation skills with the ability to establish logical flow and story and skilled in choosing the best graphic representation for points to be made. Experienced presenting to senior management
- Ability to adjust to changing needs within the organization and flexibility to change priorities as needed
- Ability to self-direct projects and work with little supervision.
- Demonstrated values-based skills and strong work ethic
- Pharmaceutical launch experience with an emphasis of building infrastructure and processes that do not currently exist
Top Skills
What We Do
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.
Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn.
For additional information on our guidelines, please visit https://scholarrock.com/community-guidelines/
For more information on how Scholar Rock collects, uses, and shares personal information, please visit: https://scholarrock.com/privacy-policy







